health
May 5, 2026
The Future of Medicines in Colombia: A Key Summit in Bogotá
On May 4 and 5, 2026, Bogotá will be the epicenter of the most important debate on health sovereignty with the Latin American Pharmaceutical Forum. What is at stake for patients?
TL;DR
- Colombia's pharmaceutical market has a significant imbalance between low-priced domestic medicines and high-cost imported ones.
- Imported medicines dominate the institutional channel, with a large portion of state purchases concentrated in single-source products.
- This reliance on foreign products weakens negotiation power and increases the risk of drug shortages.
- The national pharmaceutical industry is crucial for competition, therapeutic diversity, and price accessibility.
- A forum in Bogotá on May 4-5, 2026, will address health sovereignty, financial sustainability, and industrial development in the pharmaceutical sector.
- The goal is to determine if Latin America will move towards national pharmaceutical policies or remain fragmented and dependent.